Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,879 public trials 409 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Completed

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

NCT03571256

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Teva Investigational Site 060-0160 Gainesville, Florida, United States
  • Teva Investigational Site 060-0166 Gulf Breeze, Florida, United States
  • Teva Investigational Site 060-0161 Miami, Florida, United States
  • Teva Investigational Site 060-0151 Orlando, Florida, United States
View all 56 locations
View Trial Details
Completed

Alternatives for Reducing Chorea in Huntington Disease

NCT01897896

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Teva Investigational Site 057 Birmingham, Alabama, United States
  • Teva Investigational Site 038 Phoenix, Arizona, United States
  • Teva Investigational Site 298 Fayetteville, Arkansas, United States
  • Teva Investigational Site 052 Englewood, Colorado, United States
View all 38 locations
View Trial Details
Completed

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

NCT03452943

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Teva Investigational Site 046-0104 Dothan, Alabama, United States
  • Teva Investigational Site 046-0117 Sun City, Arizona, United States
  • Teva Investigational Site 046-0107 Rogers, Arkansas, United States
  • Teva Investigational Site 046-0126 Anaheim, California, United States
View all 42 locations
View Trial Details
Completed

Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients

NCT02273596

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Chicago, Illinois, United States
  • Clinical Trial Site Ann Arbor, Michigan, United States
View Trial Details

Related conditions